Advertisement

Topics

Gilead Sciences: VOSEVI Approved In Canada For Re-treatment Of HCV Infection

06:23 EDT 17 Aug 2017 | FinanzNachrichten

FOSTER CITY (dpa-AFX) - Gilead Sciences Canada, Inc. announced that Health Canada has granted a Notice of Compliance for VOSEVI tablets, a pan-genotypic single-tablet regimen for the treatment of ...

Original Article: Gilead Sciences: VOSEVI Approved In Canada For Re-treatment Of HCV Infection

NEXT ARTICLE

More From BioPortfolio on "Gilead Sciences: VOSEVI Approved In Canada For Re-treatment Of HCV Infection"

Advertisement
Quick Search
Advertisement
Advertisement